A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX
Status: | Completed |
---|---|
Conditions: | Arthritis, Rheumatoid Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/27/2017 |
Start Date: | November 7, 2013 |
End Date: | October 14, 2016 |
A Randomized, Double-Blind Trial Assessing the Impact of Methotrexate Discontinuation on the Efficacy of Subcutaneous Tocilizumab With Methotrexate Therapy
This randomized, multicenter, double-blind, parallel group study will evaluate the impact of
MTX discontinuation on the efficacy of SC TCZ in participants with moderate to severe active
rheumatoid arthritis who have an inadequate response to current MTX therapy. Participants
will initiate treatment with TCZ weekly or every 2 weeks along with MTX at a stable dose
orally in an open-label manner for 24 weeks. Participants with a disease activity score based
on 28 joints (DAS28) less than or equal to (=) 3.2 at Week 24, will be randomized to either
continue receiving a stable dose of MTX or to switch to matching placebo up to Week 52.
Participants without a DAS28 score =3.2 at Week 24, will continue the same treatment in a
non-randomized open-label manner up to Week 52.
MTX discontinuation on the efficacy of SC TCZ in participants with moderate to severe active
rheumatoid arthritis who have an inadequate response to current MTX therapy. Participants
will initiate treatment with TCZ weekly or every 2 weeks along with MTX at a stable dose
orally in an open-label manner for 24 weeks. Participants with a disease activity score based
on 28 joints (DAS28) less than or equal to (=) 3.2 at Week 24, will be randomized to either
continue receiving a stable dose of MTX or to switch to matching placebo up to Week 52.
Participants without a DAS28 score =3.2 at Week 24, will continue the same treatment in a
non-randomized open-label manner up to Week 52.
Inclusion Criteria:
- Body weight =150 kg
- Active moderate to severe rheumatoid arthritis (DAS28 >/=4.4) according to the revised
1987 ACR criteria at screening and baseline (prior to treatment on Day 1)
- Currently receiving oral MTX for at least 24 weeks and on a stable oral dose of at
least 15 mg/week for at least 6 weeks prior to treatment (Day 1), with the following
exception: a stable dose of at least 10 mg/week is allowed for participants with a
body weight <50 kg or calculated glomerular filtration rate (or creatinine clearance)
<60 milliliters per minute (mL/min)
- History of parenteral (SC or intramuscular [IM]) MTX is allowed, but not within 6
weeks prior to treatment (Day 1). Participants must not have a documented, clinically
significant intolerance to oral MTX and must be receiving oral MTX at a dose of 15
mg/week for at least 6 weeks prior to treatment (Day 1)
- Participants who have received one prior anti-tumor necrosis factor (TNF) must have
discontinued etanercept, infliximab, certolizumab, adalimumab, or golimumab for at
least 6 months prior to screening
- Oral corticosteroids must have been =10 mg/day prednisone (or equivalent) and stable
for at least 25 out of 28 days prior to treatment (Day 1)
- Participants receiving treatment on an outpatient basis
Exclusion Criteria:
- Documented medical history of significant intolerance to oral MTX >/=15 mg/week
- Participants receiving other (non-MTX) disease modifying anti-rheumatic drugs (DMARDs)
within 8 weeks of screening
- Previous treatment with abatacept, rituximab, tofacitinib, or anakinra
- Treatment with parenteral corticosteroids within 4 weeks prior to treatment
- Previous treatment with cell-depleting therapies or alkylating agents
- Previous treatment with TCZ
- Major surgery (including joint surgery) within 8 weeks prior to screening or planned
major surgery during the study
- Rheumatic autoimmune disease other than rheumatoid arthritis
- Non-rheumatic active autoimmune diseases (for example, inflammatory bowel diseases,
psoriasis, multiple sclerosis)
- Prior history of or current inflammatory joint disease other than rheumatoid arthritis
- Functional Class IV according to the revised (1987) ACR criteria for rheumatoid
arthritis
- History of severe allergic or anaphylactic reactions to human, humanized, or murine
monoclonal antibodies
- Evidence of significant uncontrolled concomitant diseases; uncontrolled disease states
where flares are commonly treated with oral or parenteral corticosteroids
- Active current or history of recurrent infection, or any major episode of infection
requiring hospitalization or treatment with intravenous antibiotics within 4 weeks
prior to screening or oral antibiotics within 2 weeks prior to screening
- Active tuberculosis requiring treatment within the previous 3 years
- History of or currently active primary or secondary immunodeficiency
- Pregnant or breast-feeding women
- Positive for hepatitis B or hepatitis C infection
- For potential MRI substudy participants: the presence of any metal-containing device
or object in the body
We found this trial at
155
sites
University of Colorado Hospital, Site Top medical professionals, superior medicine and progressive change make University...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
4 Vanderbilt Park Drive
Asheville, North Carolina 28803
Asheville, North Carolina 28803
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
1711 Saint Julian Place
Columbia, South Carolina 29204
Columbia, South Carolina 29204
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
101 East Valencia Mesa Drive
Fullerton, California 92835
Fullerton, California 92835
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
1255 Hillrise Circle
Las Cruces, New Mexico 88011
Las Cruces, New Mexico 88011
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials